IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 20FR12G/A SEC Filings
Registration of securities [Section 12(g)]: [Amend]

NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1997-04-09
NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1997-04-03
NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1997-03-20
NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1997-02-21
NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1997-01-31
NYMOX PHARMACEUTICAL CORP, 20FR12G/A, 1996-12-09


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission